News

Alstom Q3 2024/25: Strong Orders and Solid Sales Growth

Alstom Q3 2024/25: Strong Orders and Solid Sales Growth

Alstom Reports Promising Q3 Results for Fiscal Year 2024/25

Alstom, a leader in sustainable mobility solutions, has shared its financial results for the third quarter of the fiscal year 2024/25, reaffirming its outlook for the year. During this period, the company secured an impressive order intake of €4.3 billion, bringing the total for the first nine months up to €15.2 billion.

Order Intake and Sales Highlights

In the third quarter, Alstom's sales reached €4.7 billion, a significant increase of 5.3% compared to last year. Notable aspects of these results include a 6.9% organic growth, indicating robust demand in various sectors. The positive trend in order intake showcases the company's firm footing in a supportive rail market, underpinned by a strong portfolio mix.

Order Breakdown

The order intake for the quarter also highlights the expansion of Alstom's product offerings, particularly in Signalling and Services, which constituted 65% of the third quarter's orders. Such strong performance is crucial given the increasing demand for advanced rail signaling solutions across the globe.

Geographic Performance Analysis

Regionally, Europe emerged as a key market, contributing 64% of the total orders. Alstom has been making strides with significant projects, including a €520 million order for SNCF Voyageurs to deliver additional RER NG trains. Such initiatives reflect Alstom's commitment to enhancing rail infrastructure to meet rising passenger demand.

Financial Outlook for FY 2024/25

Looking ahead, Alstom maintains an optimistic outlook for FY 2024/25, projecting a book-to-bill ratio above 1 and organic sales growth of around 5%. This positive forecast is supported by a solid order backlog, which stood at €94.7 billion as of December 31, empowering the company with strong visibility for future sales.

Cash Flow and Profit Margins

Furthermore, Alstom anticipates a free cash flow within the range of €300 million to €500 million, alongside an adjusted EBIT margin of approximately 6.5%. The company's strategic focus on cost efficiency and effective project execution are pivotal in driving these promising financial metrics.

Recent Project Deliveries

In terms of project deliveries, Alstom has made significant progress. The inauguration of Mumbai Metro's Aqua Line marked a key milestone, showcasing the company's expertise in delivering complex rail solutions. Additionally, Alstom is progressing with its automated metro projects in Taiwan and various other global locations, reinforcing its position as a leader in the mass transit sector.

Conclusion

With a strong financial foundation and an impressive order book, Alstom's future appears bright as it continues to innovate and expand its services globally. The company’s commitment to sustainable transportation solutions is evident, and it stands poised to capture further market opportunities as the demand for efficient rail systems grows.

Frequently Asked Questions

What were Alstom's key financial figures for Q3 2024/25?

Alstom reported an order intake of €4.3 billion and sales of €4.7 billion, with a year-on-year sales increase of 5.3%.

What is Alstom's outlook for FY 2024/25?

The company expects a book-to-bill ratio above 1, organic sales growth around 5%, and a free cash flow of €300 to €500 million.

How is Alstom addressing market demand?

Alstom is actively rebalancing its order portfolio, focusing on growth sectors such as Signalling and Services while executing cost-efficiency measures.

What projects has Alstom recently completed?

Recent notable projects include the Mumbai Metro's Aqua Line and several automated metro trains in Taiwan, showcasing Alstom's capability in modern rail solutions.

What percentage of orders comes from Europe?

In Q3 2024/25, Europe accounted for 64% of Alstom's total order intake, highlighting the strength of the European rail market for the company.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ribo Advances Lipid Disorder Strategy with SR122 Trial

Updated Category News Views 114

Ribo's New Chapter in Lipid Disorders For those keeping tabs on the cutting-edge of lipid research, Ribo’s latest maneuver isn't one to skim over. The company, hailing from both Suzhou and Sweden, just moved forward by submitting its Phase I Clinical Trial Application in Europe for a fascinating compound: SR122. This development isn’t just another filing; it marks a...

Continue Reading
Quest Diagnostics at Jefferies Conference: What’s Next?

Updated Category News Views 65

Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...

Continue Reading
Burtch Works Joins Databricks: Fueling AI Success

Updated Category News Views 20

Game-Changer for AI Talent Market First off, let me tell you, in this data-driven world, finding solid AI talent is like hitting the jackpot. Burtch Works teaming up with Databricks? That's like leaping into a goldmine fully prepared. We're talking about forward-deployed engineers and specialized AI talent coming straight to your door. Closing the Impossible Talent Gap...

Continue Reading
Bimbo Bakeries Teamsters Gear Up for Strike in NJ

Updated Category News Views 102

A Brewing Storm at Bimbo Bakeries The morning air in East Brunswick fills with more than just the scent of fresh bread; there’s a tension you can slice through with a butter knife. Unwavering and fired-up, over 90 workers at Bimbo Bakeries have thrown their hats into the ring, ready to strike to protect something as sacred as the dough they churn—Teamsters' health...

Continue Reading
Zura Bio Faces Tough Road After Trial Failure

Updated Category News Views 155

Investor Dilemma: ZURA Takes a Nosedive November 9, 2026, wasn't a day to remember for anyone holding shares in Zura Bio. If ever there's a classic lesson in biotech investing's volatility, this is it: shares of Zura Biotech (NASDAQ:ZURA) cratered by about 72% after news broke that their much-hyped Phase 2 TibuSHIELD trial for tibulizumab hit the skids. For a company that...

Continue Reading
Gold.com Faces Fiduciary Investigation by Levi & Korsinsky

Updated Category News Views 56

Gold.com in Hot Water: What Shareholders Need to Know You ever wonder how firms like Gold.com find themselves in sticky situations before the ink's dry on the quarterly report? Well, strap in because Levi & Korsinsky, LLP is poking around to see if some officers and directors over there have taken a stroll down Breach Avenue. And let me tell you, if you're holding onto...

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 115

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Inner City Visions Celebrates Two Decades of Impact

Updated Category News Views 126

Alfred Lomas' Transformation Fuels Lasting Change Once upon a time, Alfred Lomas was known as a brawler in the rough patches of South L.A., running with gangs and entangled in violence. But the story flipped, and instead of leaning into chaos, Lomas leaned into hope. That personal turnaround isn't just a headline—it's the crux behind Inner City Visions (ICV), the...

Continue Reading
Mesh Security Bolsters Team with Five Cybersecurity Experts

Updated Category News Views 252

New Blood in Cybersecurity: Mesh's Strategic Moves Ever felt like the cybersecurity world is in a constant game of catch-up? You're not wrong. In today's digital battleground, companies don't just need more tools—they need collective wisdom to bind it all together. And it seems like Mesh Security just caught onto that notion, stacking their deck with five new...

Continue Reading
Charitable Giving Turbocharges E-commerce Conversion Rates

Updated Category News Views 50

Charitable Giving: The Secret Sauce for E-commerce Success In an e-commerce arena teeming with bland sameness, charitable giving is proving to be a game-changing hook. That's right—brands partnering with Change and DailyKarma have found a magic formula where customers flourish and causes benefit. With over $7.4 million in donations spread across more than 3 million...

Continue Reading

Top 5 Most Recently Viewed Articles

Get A Drip Names New CMO Amid Longevity Boom

Updated Category News Views 21

So, here's a curveball in the health gig—longevity's caught a second wind. And who's riding the wave? Get A Drip, the UK hotshot in the wellness league. They've just snagged Dr. Luke Pratsides as their new Chief Medical Officer. Imagine adding a sharp arrow to the quiver at a time when folks are head-over-heels for living longer and staying healthier. Longevity at the...

Continue Reading
Class Action Lawsuit Alert for Marex Group Investors - Act Now!

Updated Category News Views 157

Attention Investors: Marex Group Class Action Lawsuit Announced Investors in Marex Group plc (NASDAQ: MRX) should take note of an important development. A class action lawsuit has been initiated against Marex on behalf of those who purchased shares during the specified time frame. This legal action addresses serious allegations of financial misconduct, leading to...

Continue Reading
Navigating Political Challenges: Macron's Strategy with Barnier

Updated Category News Views 69

Understanding Barnier's New Role in French Politics After navigating the intricate Brexit negotiations, Michel Barnier has now stepped into a demanding role as Prime Minister. This position is crucial for tackling the urgent challenges within France's divided political environment. Challenges Awaiting Barnier Emmanuel Macron selected Barnier to steer his government...

Continue Reading
Verona Pharma Receives Shareholder Approval for Merck Deal

Updated Category News Views 211

Verona Pharma's Shareholders Greenlight Merck Acquisition In a significant step for Verona Pharma, shareholders have given the green light for the proposed acquisition by Merck & Co., marking a pivotal moment in the biopharmaceutical company's journey. Verona Pharma plc, listed on Nasdaq under the ticker VRNA, focuses on developing innovative therapies for chronic...

Continue Reading
2024 Luxury Resale Insights from The RealReal

Updated Category News Views 818

Insights from The RealReal's 2024 Luxury Resale Report Consumers Lead the Charge, Redefining Trends and Investing in Lasting Value The RealReal, the largest online marketplace for authenticated resale luxury goods, has unveiled its seventh annual 2024 Luxury Resale Report. This extensive report draws on 13 years of data to analyze the current state of luxury resale,...

Continue Reading